4//SEC Filing
Lisicki Robert 4
Accession 0001628280-22-000338
CIK 0001080709other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:00 PM ET
Size
5.1 KB
Accession
0001628280-22-000338
Insider Transaction Report
Form 4
Lisicki Robert
EVP, Chief Commercial Officer
Transactions
- Award
Common Stock
2022-01-03+21,462→ 37,563 total
Footnotes (1)
- [F1]The amount represents restricted stock units that vest over four years, with 25% of the shares underlying the restricted stock units vesting on February 15, 2023, and the remainder vesting quarterly over the following three years in equal installments (except as otherwise necessary to avoid vesting of a fractional share), with such quarterly vesting dates occurring on the 15th of May, August, November, and February. The shares underlying the restricted stock units will be issued upon vesting and release of the restricted stock units.
Documents
Issuer
ARENA PHARMACEUTICALS INC
CIK 0001080709
Entity typeother
Related Parties
1- filerCIK 0001779614
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:00 PM ET
- Size
- 5.1 KB